Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

2.
3.

Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.

Owen MC, Borg JY, Soria C, Soria J, Caen J, Carrell RW.

Blood. 1987 May;69(5):1275-9.

4.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

Jørgensen M, Petersen LC, Thorsen S.

J Lab Clin Med. 1984 Aug;104(2):245-56.

PMID:
6747440
5.

Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.

Lane DA, Lowe GD, Flynn A, Thompson E, Ireland H, Erdjument H.

Br J Haematol. 1987 Aug;66(4):523-7.

PMID:
3663509
6.

Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135.

Brennan SO, George PM, Jordan RE.

FEBS Lett. 1987 Jul 27;219(2):431-6.

7.

Antithrombin-heparin affinity reduced by fucosylation of carbohydrate at asparagine 155.

Garone L, Edmunds T, Hanson E, Bernasconi R, Huntington JA, Meagher JL, Fan B, Gettins PG.

Biochemistry. 1996 Jul 9;35(27):8881-9.

PMID:
8688424
8.
9.

Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.

Olson ST, Frances-Chmura AM, Swanson R, Björk I, Zettlmeissl G.

Arch Biochem Biophys. 1997 May 15;341(2):212-21.

PMID:
9169007
10.

Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.

Lane DA, Flynn A, Ireland H, Erdjument H, Samson D, Howarth D, Thompson E.

Br J Haematol. 1987 Apr;65(4):451-6.

PMID:
3580302
12.

Expression of functionally active human antithrombin III.

Stephens AW, Siddiqui A, Hirs CH.

Proc Natl Acad Sci U S A. 1987 Jun;84(11):3886-90.

13.

Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.

Tripodi A, Krachmalnicoff A, Mannucci PM.

Thromb Haemost. 1986 Dec 15;56(3):349-52.

PMID:
3563966
14.

Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.

J Clin Invest. 1986 Mar;77(3):887-93.

15.

Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.

Ersdal-Badju E, Lu A, Peng X, Picard V, Zendehrouh P, Turk B, Björk I, Olson ST, Bock SC.

Biochem J. 1995 Aug 15;310 ( Pt 1):323-30.

16.
17.

Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.

Wolf M, Boyer-Neumann C, Meyer D, Tripodi A, Mannucci PM, Larrieu MJ.

Thromb Haemost. 1987 Oct 28;58(3):888-92.

PMID:
3433251
18.

An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.

Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.

Br J Haematol. 1987 Aug;66(4):515-22.

PMID:
3663508
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk